Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Shakeup at FoxHollow: Ron Steckel replaces David Martin as COO, and Richard Zimmer replaces Bill Hoffman as VP-sales. Steckel moves up from senior VP-operations and research & development, where he focused on improving operating efficiency. Zimmer has spent two years with FoxHollow, serving as director of sales since October. The firm recently announced plans for new studies of its SilverHawk plaque excision system (1"The Gray Sheet" Jan. 16, 2006, p. 7). However, FoxHollow's stock has dropped 38.5% from $45.46 on Dec. 12, when the firm announced the resignation of CEO Robert Thomas, to close Feb. 10 at $27.95 (2"The Gray Sheet" Jan. 9, 2006, p. 13)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel